Matches in SemOpenAlex for { <https://semopenalex.org/work/W2764187452> ?p ?o ?g. }
- W2764187452 endingPage "8514" @default.
- W2764187452 startingPage "8482" @default.
- W2764187452 abstract "In an effort to identify new antidiabetic agents, we have discovered a novel family of (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine analogues which are inhibitors of human glycogen synthase kinase 3 (GSK3). We developed efficient synthetic routes to explore a wide variety of substitution patterns and convergently access a diverse array of analogues. Compound 1 (CHIR-911, CT-99021, or CHIR-73911) emerged from an exploration of heterocycles at the C-5 position, phenyl groups at C-4, and a variety of differently substituted linker and aminopyridine moieties attached at the C-2 position. These compounds exhibited GSK3 IC50s in the low nanomolar range and excellent selectivity. They activate glycogen synthase in insulin receptor-expressing CHO-IR cells and primary rat hepatocytes. Evaluation of lead compounds 1 and 2 (CHIR-611 or CT-98014) in rodent models of type 2 diabetes revealed that single oral doses lowered hyperglycemia within 60 min, enhanced insulin-stimulated glucose transport, and improved glucose disposal without increasing insulin levels." @default.
- W2764187452 created "2017-10-20" @default.
- W2764187452 creator A5005806202 @default.
- W2764187452 creator A5006564372 @default.
- W2764187452 creator A5008226259 @default.
- W2764187452 creator A5010148584 @default.
- W2764187452 creator A5016595929 @default.
- W2764187452 creator A5022864991 @default.
- W2764187452 creator A5029870688 @default.
- W2764187452 creator A5052087526 @default.
- W2764187452 creator A5054071613 @default.
- W2764187452 creator A5054944261 @default.
- W2764187452 creator A5056883468 @default.
- W2764187452 creator A5062775260 @default.
- W2764187452 creator A5063542276 @default.
- W2764187452 creator A5064076137 @default.
- W2764187452 creator A5066380283 @default.
- W2764187452 creator A5069164286 @default.
- W2764187452 creator A5069380980 @default.
- W2764187452 creator A5080332365 @default.
- W2764187452 creator A5080831528 @default.
- W2764187452 creator A5085050249 @default.
- W2764187452 creator A5085602158 @default.
- W2764187452 creator A5087021346 @default.
- W2764187452 date "2017-10-10" @default.
- W2764187452 modified "2023-09-25" @default.
- W2764187452 title "Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3" @default.
- W2764187452 cites W1527792826 @default.
- W2764187452 cites W1559064733 @default.
- W2764187452 cites W1570362997 @default.
- W2764187452 cites W1965034925 @default.
- W2764187452 cites W1966689737 @default.
- W2764187452 cites W1968344408 @default.
- W2764187452 cites W1975588287 @default.
- W2764187452 cites W1975815687 @default.
- W2764187452 cites W1975829682 @default.
- W2764187452 cites W1978714931 @default.
- W2764187452 cites W1982219886 @default.
- W2764187452 cites W1982958012 @default.
- W2764187452 cites W1986362116 @default.
- W2764187452 cites W1986811179 @default.
- W2764187452 cites W1987138662 @default.
- W2764187452 cites W1988605096 @default.
- W2764187452 cites W1988623463 @default.
- W2764187452 cites W1989411375 @default.
- W2764187452 cites W1999568358 @default.
- W2764187452 cites W2001866120 @default.
- W2764187452 cites W2003721045 @default.
- W2764187452 cites W2004660376 @default.
- W2764187452 cites W2011588737 @default.
- W2764187452 cites W2016997249 @default.
- W2764187452 cites W2017592134 @default.
- W2764187452 cites W2017878931 @default.
- W2764187452 cites W2026395206 @default.
- W2764187452 cites W2026800046 @default.
- W2764187452 cites W2033454758 @default.
- W2764187452 cites W2035376760 @default.
- W2764187452 cites W2037254599 @default.
- W2764187452 cites W2037923368 @default.
- W2764187452 cites W2038063954 @default.
- W2764187452 cites W2046822015 @default.
- W2764187452 cites W2048652222 @default.
- W2764187452 cites W2049875806 @default.
- W2764187452 cites W2054594832 @default.
- W2764187452 cites W2054690921 @default.
- W2764187452 cites W2056188654 @default.
- W2764187452 cites W2063620211 @default.
- W2764187452 cites W2064913654 @default.
- W2764187452 cites W2068535486 @default.
- W2764187452 cites W2074125306 @default.
- W2764187452 cites W2076305331 @default.
- W2764187452 cites W2077856523 @default.
- W2764187452 cites W2085564578 @default.
- W2764187452 cites W2089909716 @default.
- W2764187452 cites W2090863421 @default.
- W2764187452 cites W2094463479 @default.
- W2764187452 cites W2098017074 @default.
- W2764187452 cites W2100880328 @default.
- W2764187452 cites W2104979495 @default.
- W2764187452 cites W2108564760 @default.
- W2764187452 cites W2109479865 @default.
- W2764187452 cites W2112578787 @default.
- W2764187452 cites W2124026197 @default.
- W2764187452 cites W2124867155 @default.
- W2764187452 cites W2126317966 @default.
- W2764187452 cites W2130357785 @default.
- W2764187452 cites W2132629607 @default.
- W2764187452 cites W2138266173 @default.
- W2764187452 cites W2144825781 @default.
- W2764187452 cites W2145742341 @default.
- W2764187452 cites W2146812359 @default.
- W2764187452 cites W2146895097 @default.
- W2764187452 cites W2149598894 @default.
- W2764187452 cites W2160555596 @default.
- W2764187452 cites W2161071101 @default.
- W2764187452 cites W2162877239 @default.
- W2764187452 cites W2163098588 @default.
- W2764187452 cites W2167657940 @default.